DARA reports diabetes drug Phase 1b positive trial results
DB959 is a peroxisome proliferator activated receptor (PPAR)-delta/gamma agonist which activates certain nuclear receptors that regulate the genes involved in controlling blood sugar levels and certain lipids. The
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.